Valencia Antonio, Kochevar Irene E
Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
J Invest Dermatol. 2008 Jan;128(1):214-22. doi: 10.1038/sj.jid.5700960. Epub 2007 Jul 5.
UVA radiation is a major environmental stress on skin, causing acute and chronic photodamage. These responses are mediated by reactive oxygen species (ROS), although the cellular source of these ROS is unknown. We tested the hypotheses that UVA-induced activation of nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is required for ROS generation in human keratinocytes (HK) and that these ROS initiate rapid prostaglandin E2 (PGE2) synthesis. Treatment of HK with a non-toxic dose of UVA rapidly increased NADPH oxidase activity and intracellular ROS, which were partially blocked by an inhibitor of NADPH oxidase and by a mitochondria-selective antioxidant. Depleting the Nox1 isoform of the catalytic subunit of NADPH oxidase using small interfering RNA (siRNA) blocked the UVA-induced ROS increase, indicating that ROS produced by mitochondria or other sources are downstream from Nox1. Nox1 siRNA also blocked UVA-initiated PGE2 synthesis. The mechanism for activation of Nox1 is mediated by an increase in intracellular calcium. Ceramide, which has been proposed to mediate responses to UVA in HK, also activated NADPH oxidase. These results indicate that UVA activates Nox1-based NADPH oxidase to produce ROS that stimulate PGE2 synthesis, and that Nox1 may be an appropriate target for agents designed to block UVA-induced skin injury.
紫外线A辐射是皮肤面临的主要环境压力,会导致急性和慢性光损伤。这些反应由活性氧(ROS)介导,尽管这些ROS的细胞来源尚不清楚。我们检验了以下假设:紫外线A诱导的烟酰胺腺嘌呤二核苷酸磷酸(NADPH)氧化酶激活是人类角质形成细胞(HK)中ROS产生所必需的,并且这些ROS启动快速前列腺素E2(PGE2)合成。用无毒剂量的紫外线A处理HK会迅速增加NADPH氧化酶活性和细胞内ROS,这被NADPH氧化酶抑制剂和线粒体选择性抗氧化剂部分阻断。使用小干扰RNA(siRNA)耗尽NADPH氧化酶催化亚基的Nox1亚型可阻断紫外线A诱导的ROS增加,表明线粒体或其他来源产生的ROS在Nox1下游。Nox1 siRNA也阻断了紫外线A启动的PGE2合成。Nox1激活的机制由细胞内钙增加介导。神经酰胺已被提出介导HK对紫外线A的反应,它也激活了NADPH氧化酶。这些结果表明,紫外线A激活基于Nox1的NADPH氧化酶以产生活性氧,从而刺激PGE2合成,并且Nox1可能是设计用于阻断紫外线A诱导的皮肤损伤的药物的合适靶点。